cysteine has been researched along with Multiple System Atrophy in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, S; Kaminou, T; Kanasaki, Y; Miyoshi, F; Ogawa, T; Shinohara, Y; Tanabe, Y | 1 |
| Hanaoka, T; Hazama, Y; Kimura, N; Kumamoto, T; Masuda, T; Nomura, Y; Okazaki, T | 1 |
| Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y | 1 |
| Antonini, A; Benti, R; De Notaris, R; Eidelberg, D; Feigin, A; Fukuda, M; Mentis, MJ; Moeller, JR; Pezzoli, G | 1 |
| Bosman, T; Santens, P; Van Laere, K | 1 |
| Bosman, T; De Reuck, J; Dierckx, R; Mortelmans, L; Santens, P; Van Laere, K | 1 |
| Hattori, T; Sakakibara, R; Uchida, Y; Uchiyama, T; Yamanishi, T | 1 |
| Kaji, R; Kawakami, H; Kuno, S; Nishimura, M | 1 |
| El Fakhri, G; Habert, MO; Kas, A; Kijewski, MF; Lacomblez, L; Maksud, P; Malek, Z | 1 |
| Eckert, T; Edwards, C; Eidelberg, D; Lewis, DE; Santens, P; Tang, C; Van Laere, K | 1 |
3 trial(s) available for cysteine and Multiple System Atrophy
| Article | Year |
|---|---|
Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.
Topics: Brain; Cysteine; Diagnosis, Differential; Discriminant Analysis; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Parkinson Disease; Radiopharmaceuticals; Reference Standards; Reference Values; Subtraction Technique; Tomography, Emission-Computed, Single-Photon | 2003 |
Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.
Topics: Algorithms; Brain; Cysteine; Diagnosis, Differential; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2004 |
Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy.
Topics: Cysteine; Diagnosis, Differential; Feasibility Studies; Female; Humans; Image Enhancement; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Parkinson Disease; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Tropanes | 2006 |
7 other study(ies) available for cysteine and Multiple System Atrophy
| Article | Year |
|---|---|
Significance of combined use of MRI and perfusion SPECT for evaluation of multiple system atrophy, cerebellar type.
Topics: Aged; Cysteine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2016 |
Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT.
Topics: Aged; Brain; Brain Mapping; Cerebellum; Cerebrovascular Circulation; Cysteine; Female; Functional Laterality; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Spinocerebellar Degenerations; Stereotaxic Techniques; Tomography, Emission-Computed, Single-Photon | 2009 |
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2011 |
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Topics: Aged; Brain; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Reduced cerebellar vermis activation during urinary storage and micturition in multiple system atrophy: 99mTc-labelled ECD SPECT study.
Topics: Aged; Brain Mapping; Cerebellum; Cysteine; Female; Functional Laterality; Humans; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Urinary Bladder; Urination | 2004 |
Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain-Derived Neurotrophic Factor; Cysteine; Female; Genetic Predisposition to Disease; Humans; Japan; Male; Methionine; Middle Aged; Multiple System Atrophy; Parkinson Disease; Polymorphism, Genetic; Threonine; Valine | 2005 |
Quantification of Parkinson's disease-related network expression with ECD SPECT.
Topics: Algorithms; Brain; Cysteine; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Multiple System Atrophy; Organotechnetium Compounds; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Signal Transduction; Tomography, Emission-Computed, Single-Photon | 2007 |